ZENA.V - Zenabis Global Inc.

TSXV - TSXV Delayed Price. Currency in CAD
1.8600
-0.0300 (-1.59%)
At close: 4:35PM EDT
Stock chart is not supported by your current browser
Previous Close1.8900
Open1.9700
Bid1.8500 x 0
Ask1.8500 x 0
Day's Range1.8300 - 1.9700
52 Week Range1.6200 - 6.2500
Volume926,651
Avg. Volume342,887
Market Cap354.38M
Beta (3Y Monthly)-2.43
PE Ratio (TTM)N/A
EPS (TTM)-0.3150
Earnings DateFeb 20, 2019 - Feb 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
  • CNW Group2 days ago

    Zenabis Closes Previously Announced Public Offering and Exercise of Over-allotment Option

    VANCOUVER , April 17, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") announces today that it has closed its previously announced fully-marketed, "best efforts" offering (the "Offering") of 12,777,777 units of the Company (each, a "Unit"), which includes the exercise of the agents' over-allotment option in full, at a price of $2.25 per Unit, for aggregate gross proceeds to the Company of approximately $28.75 million , before deducting commissions and expenses of the Offering. Each Unit consists of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a Common Share at a price of $2.75 for a period of 36 months from today's date.  The Warrants have been approved for listing on the TSX Venture Exchange ("TSXV"), under the symbol "ZENA.WT", and trading of the Warrants on the TSXV is expected to commence on April 22, 2019 .

  • CNW Group8 days ago

    IIROC Trading Resumption - ZENA

    IIROC Trading Resumption - ZENA

  • GlobeNewswire8 days ago

    Zenabis Announces Pricing and Update to Terms of Public Offering

    Zenabis Global Inc (ZENA.V) (“Zenabis” or the “Company”) announces that, further to the Company's press release dated April 10, 2019, its fully-marketed, “best efforts” offering (the "Offering") will be of units of the Company (each, a "Unit") at a price of $2.25 per Unit (the "Offering Price"). Each Unit will consist of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a Common Share at a price of $2.75 for a period of 36 months following the closing date of the Offering.

  • CNW Group8 days ago

    IIROC Trading Halt - ZENA

    IIROC Trading Halt - ZENA

  • GlobeNewswire9 days ago

    Zenabis Files Preliminary Prospectus Supplement for Offering of Common Shares

    Zenabis Global Inc (ZENA.V) (“Zenabis” or the “Company”) announces that it has today filed a preliminary prospectus supplement (the “Supplement”) to its short form base shelf prospectus dated April 9, 2019 (the “Shelf Prospectus”) in connection with a fully-marketed, “best efforts” offering of its common shares (the “Offering”).  The Supplement was filed with the securities regulatory authorities in each of the provinces of Canada, except Québec. The Offering is expected to raise total gross proceeds of approximately $25.0 million before deducting commissions and estimated expenses of the Offering.  The Company intends to use the net proceeds of the Offering to fund the cost of conversion of its facilities to cannabis production and for working capital.

  • CNW Group9 days ago

    Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus

    Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus

  • CNW Group18 days ago

    Zenabis Global Inc. Announces Resignation of Donald Fairholm from Board of Directors

    VANCOUVER , April 1, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) wishes to announce that Donald Fairholm has resigned from its board of directors. The board of directors has initiated the process of finding a new director to fill the vacancy on the board. Note: Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  • CNW Group23 days ago

    Zenabis Completes $15 million First Tranche of $75 million Convertible Debenture Financing

    VANCOUVER , March 27, 2019 /CNW/ - Zenabis Global Inc (ZENA.V) ("Zenabis" or the "Company") is pleased to announce that it has closed its previously announced bought deal private placement of 15,000 unsecured convertible debentures (the "Convertible Debentures") of the Company, at a price of $1,000 per Convertible Debenture (the "Issue Price") for gross proceeds of $15,000,000 (the "Offering"). The Company intends to use the net proceeds of the Offering to fund the cost of conversion of its facilities to cannabis production and for working capital.

  • Market Exclusive28 days ago

    Cannabis Stock News Daily Roundup March 21

    AgraFlora Organics International (CSE: AGRA) (OTCPK: PUFXF) is teaming up with Dixie Brands (CSE: DIXI.U) (OTC: DXBRF) (Frankfurt: 0QV) to the manufacture, sale and distribution of cannabis-infused products within legalized markets in the European Union. According to a research report by Prohibition Partners, the cannabis market in the EU may represent as much as €123 […]The post Cannabis Stock News Daily Roundup March 21 appeared first on Market Exclusive.

  • GlobeNewswire29 days ago

    Drink it Up; Cannabis/Hemp Infused Beverage Distribution Agreements In Full Swing

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the latest distribution agreements for cannabis/hemp infused beverages as companies prepare for legal sales. American Premium Water Corporation (OTC: HIPH) is looking at both avenues, having announced that it has launched an updated e-commerce website for its LALPINA CBD brand. The new website will be at www.lalpinahydrocbd.com and will utilize GreenBox POS’ proprietary blockchain based payment process technology, which will allow for uninterrupted e-commerce sales.

  • CNW Group29 days ago

    Zenabis Enters European Pharmaceutical Cannabis Market

    VANCOUVER , March 21, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) today announced a significant expansion of its supply opportunity through its entrance into the European pharmaceutical cannabis market. Zenabis has entered into a Letter of Intent ("LOI") towards a definitive supply arrangement with Farmako GmbH ("Farmako"), a research-based pharmaceutical company headquartered in Frankfurt, Germany . Pursuant to the LOI, Farmako has committed to an initial purchase of CBD isolate.

  • CNW Grouplast month

    Zenabis Launches Zen Craft Grow: Program to Connect Micro-Cultivators to National Consumers

    VANCOUVER , March 19, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) has signed its first exclusive, definitive supply agreement under its Zen Craft Grow program. This first Zen Craft Grow agreement is an exclusive supply agreement between Zenabis, as a standard processor, and a micro-cultivator in the final stages of receiving its license that will bring unique genetics and small-batch, artisanally grown cannabis to discerning adult-use consumers across Canada . The Zen Craft Grow program reflects Zenabis' ongoing commitment to offer consumers a range of unique and high-quality products.

  • CNW Grouplast month

    Zenabis Provides Operational Update

    VANCOUVER , March 18, 2019 /CNW/ - Zenabis Global Inc (ZENA.V) ("Zenabis" or the "Company") is pleased to provide this update on certain operational matters. Construction at Zenabis Atholville is progressing on schedule. The remaining conversion work is expected to add an additional 25,000 kg in annual production capacity, which will become operational in stages in the second quarter of 2019.

  • CNW Grouplast month

    Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF

    Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF

  • Market Exclusivelast month

    Cannabis Stock News Daily Roundup March 18

    VIASPACE (OTC: VSPC) subsidiary Bad Love Cosmetics has completed fabrication of the component containers for its CBD lip product line. In a statement, VIASPACE Chairman and Acting CEO Dr. Kevin Schewe states: "We are proceeding with our 2019 business plans for VIASPACE to generate revenues from a business model with three lines of business activities." […]The post Cannabis Stock News Daily Roundup March 18 appeared first on Market Exclusive.

  • CNW Grouplast month

    BlackShire investee company Zenabis Global is added to Horizons ETF

    TORONTO , March 18, 2019 /CNW/ - BlackShire Capital is pleased to recognize the progress being made by its investee company Zenabis Global Inc. ("Zenabis") (ZENA.V) through its incorporation into the Horizons Marijuana Life Sciences Index ETF (HMMJ.TO) (the "Horizons ETFs"). "Zenabis was one of BlackShire's first investments and remains a marquee holding of the firm. As the world's first ETF that offers direct exposure to North American-listed securities involved with cannabis production, the Horizons Marijuana Life Sciences Index ETF is designed to provide exposure to the performance of North American publicly listed life sciences companies with significant business activities in the cannabis industry.

  • CNW Grouplast month

    Zenabis Now Licensed to Sell Cannabis Oil

    VANCOUVER , March 18, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) announced today that it is now licensed to process and sell cannabis oil products in Canada . The license enables Zenabis to now sell cannabis oil produced at its Atholville, New Brunswick facility, one of the largest indoor cannabis growing facilities in Canada , where Zenabis was already processing oil. Zenabis expects to market and sell cannabis oil products to its medical clients and to adult use consumers through supply and distribution agreements that Zenabis has in place with nine Canadian jurisdictions including British Columbia , Alberta , Saskatchewan , Quebec , Nova Scotia , New Brunswick , Manitoba , Prince Edward Island , and the Yukon .

  • CNW Grouplast month

    Zenabis Confirms Fire at Langley Warehouse; No Injuries or Impact on Cannabis Production or Construction Timelines

    VANCOUVER , March 14, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) today confirmed a minor fire incident on March 14, 2019 at its Bevo Agro facility in Langley, British Columbia . This incident will not affect its cannabis production or cannabis supply commitments. Note: Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  • GlobeNewswire2 months ago

    Zenabis Announces $75 million Convertible Debenture Financing

    Zenabis Global Inc (ZENA.V) (“Zenabis” or the “Company”) is pleased to announce that it has entered into a letter of engagement with Eight Capital (the “Eight Capital Engagement”) under which Eight Capital has agreed to purchase 15,000 unsecured convertible debentures (the “Initial  Debentures”) of the Company on a “bought deal” private placement basis pursuant to applicable securities laws exemptions, at a price of $1,000 per Initial Debenture (the “Issue Price”) for gross proceeds of $15,000,000 (the “Initial Offering”). In addition, pursuant to the Eight Capital Engagement, Eight Capital has agreed to offer for sale an additional 60,000 convertible debentures (the “Additional Debentures” and, together with the Initial Debentures, the “Convertible Debentures”) at the Issue Price, for additional gross proceeds of $60,000,000 (the “Additional Offering” and, together with the Initial Offering, the “Offering”).

  • CNW Group2 months ago

    Zenabis Receives License in Nova Scotia for Third Cannabis Facility

    VANCOUVER , March 4, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) today announced that it has been approved to cultivate and grow cannabis at its 255,000 square foot facility in Stellarton, Nova Scotia . This represents the third Zenabis facility in Canada licensed to grow cannabis, adding design capacity of 18,500 kilograms of dried cannabis per year. The Stellarton facility features a highly advanced production environment that supports both growing and finished product operations, as well as new product development.

  • CNW Group2 months ago

    Quebec Becomes Ninth Canadian Jurisdiction for Zenabis Products

    VANCOUVER , Feb. 26, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) today secured a meaningful new market opportunity by reaching a letter of intent with the Société québécoise du cannabis (SQDC). Quebec is a significant cannabis market and is in close proximity to Zenabis' licensed 380,000 sq. ft. growing facility in New Brunswick , and its upcoming 255,000 sq. ft. facility in Nova Scotia . Zenabis expects to begin supplying its premium cannabis products to Quebec in the second quarter of 2019 upon completion of the Autorité des Marchés Publics public process.

  • CNW Group2 months ago

    Zenabis to Supply Premium Recreational Cannabis to Alberta

    VANCOUVER , Feb. 20, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) today announced that it will formally enter the Alberta recreational cannabis market, supplying retailers throughout the province through a Supply Agreement it has entered into with the Alberta Gaming, Liquor & Cannabis Commission (AGLC). Alberta represents the eighth province/territory that Zenabis will supply, and builds on Zenabis' significant recent momentum in developing sales and marketing channels for its complete range of products.

  • CNW Group2 months ago

    Zenabis Provides Update on Previous Financing

    VANCOUVER , Feb. 8, 2019 /CNW/ – Zenabis Global Inc. ("Zenabis") (ZENA.V) is pleased to provide an update on a previously-announced Secured Convertible Debenture financing.  Zenabis issued a secured convertible debenture in October 2017 , on which it drew $4,150,000 on October 17 , 2018.  In connection with completion of its RTO, Zenabis was not permitted to draw the remaining $20,850,000 .